Date:August 14, 2012

Karen Rabin, MD, PhD

Karen Rabin, M.D., Ph.D.Director, Leukemia Program

Associate Professor
Department of Pediatrics
Section of Hematology/Oncology
Baylor College of Medicine

Dr. Karen Rabin
1102 Bates Street, Suite 750.01
Houston, TX 77030

Phone: 832-824-4213
Fax: 832-825-1206


About Dr. Karen Rabin

Dr. Karen Rabin is a physician-scientist and full-time faculty in the Baylor College of Medicine Department of Pediatrics, Section of Pediatric Hematology and Oncology.  She is a member of the leukemia and lymphoma clinical teams and is Director of the Leukemia Program, which has the mission of providing the best possible patient care; fostering and promoting innovative research; and educating future clinicians and scientists.

Dr. Rabin has nationally-recognized expertise in the management of childhood acute lymphoblastic leukemia (ALL).  She serves as the Co-Chair of the Children’s Oncology Group ALL Classification Study AALL08B1, which determines the appropriate risk group assignment and therapy for over 2,000 children diagnosed with ALL each year.  She is also the COG Principal Investigator for Baylor College of Medicine, with responsibility for the oversight of all COG clinical trials conducted at this site.

Dr. Rabin’s laboratory research focuses on the biology of acute lymphoblastic leukemia (ALL) in children with Down syndrome, including the molecular basis for leukemogenesis in these patients, the basis for their increased risk of treatment-related toxicities, and identification of novel therapeutic targets.   Learn more about Dr. Rabin’s research laboratory.


Ph.D., Baylor College of Medicine
M.D. and Residency, University of California San Francisco
Fellowship, Stanford University
M.A., Medical Law and Ethics, Kings College London

Board Certifications

American Board of Pediatrics
American Board of Pediatrics-Hematology/Oncology

Selected Memberships

Member, American Association of Pediatrics (AAP)
Member, American Society of Hematology (ASH)
Member, American Society of Pediatric Hematology and Oncology (ASPHO)
Member, Children’s Oncology Group (COG)

Clinical Special Interests

Molecular genetics of ALL
Down syndrome ALL

Research Interests

Down syndrome ALL
Molecular genetics of ALL
Treatment-related toxicities in ALL
Identification of novel therapeutic targets

Related Links

Scholar, St. Baldrick’s Foundation, with generous support from the Daniel the Brave Fund

Learn about the Research Laboratory of Karen Rabin